Evolving Models of HIV Care (Volume 3)
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Meeting Slides
Clinical Practice Guidelines
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.
US Department of Health and Human Services (DHHS).
HIV Testing.
Centers for Disease Control and Prevention (CDC).
Interim Guidance for COVID-19 and Persons With HIV.
DHHS. June 2020.
Clinical Resources
AIDSVu.
Emory University’s Rollins School of Public Health, Gilead Sciences, Inc., and the Center for AIDS Research at Emory University (CFAR).
Database of Antiretroviral Drug Interactions.
HIV InSite. University of California, San Francisco.
HEP Drug Interactions.
University of Liverpool. Last reviewed December 2020.
National Harm Reduction Coalition.
Patient Resources
HIV Basics
Centers for Disease Control and Prevention (CDC).
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum.
Positively Aware
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of up-to-date HIV-treatment information for people living with HIV/AIDS, as well as an educational site for HIV caregivers.
Project Inform
Project Inform is an HIV and hepatitis C advocacy group fighting for effective treatments and high quality, affordable health care. It provides up-to-date information to help people make the best choices regarding their treatment and care.
Suggested Readings
Integrating Mental Health Care for People Living With HIV.
Carvalhal A. Health Care: Current Reviews. 2015;3(1).
Immediate initiation of antiretroviral therapy in the outpatient clinic.
Coffey S, Bacon O. HIV InSite. Updated May 2020.
Rapid antiretroviral therapy: time for a new standard of care.
Coffey S, et al. Clin Infect Dis. 2020 (Epub ahead of print).
Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.
Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.
HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable.
Eisinger RW, et al. JAMA. 2019;321(5):451-452.
Pathways to health: an examination of HIV-related stigma, life stressors, depression, and substance use.
Glynn TR, et al. Int J Behav Med. 2019;26(3):286-296.
Depression prevalence, antidepressant treatment status, and association with sustained HIV viral suppression among adults living with HIV in care in the United States, 2009–2014.
Gokhale RH, et al. AIDS Behav. 2019;23(12):3452-3459.
A care continuum of immediate ART for newly diagnosed patients and patients presenting later to care at a Federally Qualified Health Center in New Orleans.
Halperin J, et al. Open Forum Infect Dis. 2019;6(4):ofz161.
A strategy for PrEP clinicians to manage ambiguous HIV test results during follow-up visits.
Smith DK, et al. Open Forum Infect Dis. 2018;5(8):ofy180.
Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.
Stone. VE. Curr HIV/AIDS Rep. 2005;2(4):189-193.
Rapid ART Initiation: A Key Strategy for Ending the HIV Epidemic
Overcoming Barriers: Successful Rapid ART Initiation
Evolving Models of HIV Care (Volume 3)
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
A Phone-a-Friend CME Series – Volume 2
Incorporating New Data and Updated Guidelines Into Daily Practice
